Bank of New York Mellon Corp Buys 712,595 Shares of Morgan Stanley $MS

Bank of New York Mellon Corp grew its stake in Morgan Stanley (NYSE:MSFree Report) by 8.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 9,371,513 shares of the financial services provider’s stock after purchasing an additional 712,595 shares during the quarter. Bank of New York Mellon Corp’s holdings in Morgan Stanley were worth $1,663,725,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Brighton Jones LLC boosted its stake in shares of Morgan Stanley by 10.2% during the fourth quarter. Brighton Jones LLC now owns 12,782 shares of the financial services provider’s stock valued at $1,607,000 after purchasing an additional 1,185 shares in the last quarter. Main Street Financial Solutions LLC boosted its stake in shares of Morgan Stanley by 69.0% during the second quarter. Main Street Financial Solutions LLC now owns 8,964 shares of the financial services provider’s stock valued at $1,263,000 after purchasing an additional 3,661 shares in the last quarter. Diversify Advisory Services LLC boosted its stake in shares of Morgan Stanley by 90.9% during the second quarter. Diversify Advisory Services LLC now owns 16,148 shares of the financial services provider’s stock valued at $2,378,000 after purchasing an additional 7,688 shares in the last quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its stake in shares of Morgan Stanley by 6.3% during the second quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 263,575 shares of the financial services provider’s stock valued at $37,127,000 after purchasing an additional 15,623 shares in the last quarter. Finally, Jupiter Wealth Management LLC boosted its stake in shares of Morgan Stanley by 7.8% during the second quarter. Jupiter Wealth Management LLC now owns 52,825 shares of the financial services provider’s stock valued at $7,805,000 after purchasing an additional 3,807 shares in the last quarter. 84.19% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on MS shares. UBS Group increased their price objective on shares of Morgan Stanley from $196.00 to $214.00 in a research note on Wednesday, May 6th. Wolfe Research dropped their price objective on shares of Morgan Stanley from $221.00 to $197.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 1st. Dbs Bank increased their price objective on shares of Morgan Stanley from $185.00 to $220.00 in a research note on Thursday, May 7th. Jefferies Financial Group downgraded shares of Morgan Stanley from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 9th. Finally, Bank of America raised their target price on shares of Morgan Stanley from $220.00 to $225.00 and gave the company a “buy” rating in a research note on Thursday, April 16th. Twelve research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $205.95.

Get Our Latest Stock Report on MS

Insider Transactions at Morgan Stanley

In other news, insider Andrew M. Saperstein sold 51,668 shares of the business’s stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $188.59, for a total transaction of $9,744,068.12. Following the completion of the sale, the insider owned 282,142 shares of the company’s stock, valued at $53,209,159.78. The trade was a 15.48% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Daniel A. Simkowitz sold 14,690 shares of the business’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $189.24, for a total transaction of $2,779,935.60. Following the sale, the insider directly owned 365,802 shares of the company’s stock, valued at $69,224,370.48. This represents a 3.86% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 77,476 shares of company stock valued at $14,644,762 over the last 90 days. Corporate insiders own 0.17% of the company’s stock.

Key Headlines Impacting Morgan Stanley

Here are the key news stories impacting Morgan Stanley this week:

  • Positive Sentiment: Financial stocks are trading higher, giving Morgan Stanley a sector tailwind as investors rotate into banks and capital markets names.
  • Positive Sentiment: Morgan Stanley Expansion Capital led a $33 million growth financing for Subtle Medical, highlighting continued deal activity and exposure to AI-related healthcare investing. Business Wire: Morgan Stanley Expansion Capital Leads 33 Million Growth Financing For Subtle Medical
  • Positive Sentiment: Recent earnings results were strong, with Morgan Stanley beating both EPS and revenue estimates, which has likely helped sustain investor confidence in the stock.

Morgan Stanley Trading Up 2.0%

Shares of Morgan Stanley stock opened at $215.13 on Wednesday. Morgan Stanley has a 1 year low of $127.13 and a 1 year high of $217.03. The company has a debt-to-equity ratio of 3.52, a current ratio of 0.77 and a quick ratio of 0.77. The firm has a fifty day moving average price of $184.82 and a 200 day moving average price of $177.79. The stock has a market cap of $339.32 billion, a PE ratio of 19.49, a price-to-earnings-growth ratio of 1.58 and a beta of 1.23.

Morgan Stanley (NYSE:MSGet Free Report) last released its quarterly earnings data on Wednesday, April 15th. The financial services provider reported $3.43 earnings per share for the quarter, beating analysts’ consensus estimates of $3.02 by $0.41. Morgan Stanley had a net margin of 14.65% and a return on equity of 17.70%. The company had revenue of $20.58 billion during the quarter, compared to analysts’ expectations of $19.23 billion. During the same quarter in the previous year, the company earned $2.60 earnings per share. The firm’s revenue for the quarter was up 16.0% on a year-over-year basis. Equities research analysts predict that Morgan Stanley will post 11.85 earnings per share for the current year.

Morgan Stanley Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Thursday, April 30th were paid a dividend of $1.00 per share. The ex-dividend date of this dividend was Thursday, April 30th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 1.9%. Morgan Stanley’s payout ratio is currently 36.23%.

Morgan Stanley Company Profile

(Free Report)

Morgan Stanley (NYSE: MS) is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company’s chief executive and chairman in recent years.

The firm’s primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.

Further Reading

Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MSFree Report).

Institutional Ownership by Quarter for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.